Atlas Trials

Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Clinical trial NCT00761306 · COMPLETED

Trial details

NCT number
NCT00761306
Sponsor
H. Lundbeck A/S
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2007-06-01
Primary completion
2008-09-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.